Successful management of voriconazole-associated hyponatremia with therapeutic drug monitoring.
作者信息
Xu Ren-ai, Lin Guan-yang, Hu Lu-feng, Shi Da-wei, Ye Xiao-lan, Liu Yun-jie, Pan Xiao-feng, Zhang Chun-hong, Zhang Xiu-hua
出版信息
Antimicrob Agents Chemother. 2013 May;57(5):2422-3. doi: 10.1128/AAC.00146-13. Epub 2013 Feb 12.
Abstract
摘要
相似文献
1
Successful management of voriconazole-associated hyponatremia with therapeutic drug monitoring.通过治疗药物监测成功管理伏立康唑相关低钠血症。
Antimicrob Agents Chemother. 2013 May;57(5):2422-3. doi: 10.1128/AAC.00146-13. Epub 2013 Feb 12.
2
[Severe hyponatraemia during invasive pulmonary aspergillosis treatment with voriconazole in a octogenarian patient with chronic obstructive pulmonary disease].[一名患有慢性阻塞性肺疾病的八旬老人在接受伏立康唑治疗侵袭性肺曲霉病期间发生严重低钠血症]
Rev Esp Geriatr Gerontol. 2013 Sep-Oct;48(5):249-50. doi: 10.1016/j.regg.2013.02.002. Epub 2013 May 21.
3
Voriconazole-associated severe hyponatremia.伏立康唑相关严重低钠血症。
Med Mycol. 2012 Jan;50(1):103-5. doi: 10.3109/13693786.2011.587210. Epub 2011 Jun 15.
4
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.COPD 患者侵袭性曲霉菌病的管理：伏立康唑的合理应用。
Int J Chron Obstruct Pulmon Dis. 2009;4:279-87. doi: 10.2147/copd.s4229. Epub 2009 Aug 3.
5
Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.三岁以下儿童伏立康唑的治疗药物监测：一例报告及十例儿童伏立康唑浓度总结。
Pediatr Infect Dis J. 2012 Jun;31(6):632-5. doi: 10.1097/INF.0b013e31824acc33.
6
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.在短暂中性粒细胞减少的大鼠中，使用人药代动力学等效剂量的伏立康唑和阿尼芬净联合治疗晚期侵袭性肺曲霉病。
Antimicrob Agents Chemother. 2009 May;53(5):2005-13. doi: 10.1128/AAC.01556-08. Epub 2009 Feb 23.
7
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.伏立康唑治疗慢性肺曲霉病：一项前瞻性多中心试验。
Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3231-9. doi: 10.1007/s10096-012-1690-y. Epub 2012 Jul 11.
8
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.从静脉注射他克莫司和伏立康唑转换为口服给药会导致更明显的药物相互作用。
Eur J Clin Pharmacol. 2013 Mar;69(3):737-8. doi: 10.1007/s00228-012-1365-8. Epub 2012 Aug 10.
9
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.肺移植受者侵袭性肺曲霉病采用伏立康唑和卡泊芬净联合治疗的临床转归。
J Clin Pharm Ther. 2010 Feb;35(1):49-53. doi: 10.1111/j.1365-2710.2009.01061.x.
10
Editorial commentary: Antifungal therapeutic drug monitoring progress: getting it right the first time.社论评论：抗真菌治疗药物监测进展：首次就做对。
Clin Infect Dis. 2012 Aug;55(3):391-3. doi: 10.1093/cid/cis446. Epub 2012 May 18.
引用本文的文献
1
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents.长期应用唑类抗真菌药物相关的不良反应。
Drugs. 2019 Jun;79(8):833-853. doi: 10.1007/s40265-019-01127-8.
2
The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro.细胞色素P450 2C19基因多态性对伏立康唑体外代谢的影响。
Infect Drug Resist. 2018 Nov 1;11:2129-2135. doi: 10.2147/IDR.S179078. eCollection 2018.
本文引用的文献
1
The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.治疗药物监测对侵袭性真菌感染伏立康唑安全性和疗效的影响：一项随机对照试验。
Clin Infect Dis. 2012 Oct;55(8):1080-7. doi: 10.1093/cid/cis599. Epub 2012 Jul 3.
2
Voriconazole-induced phototoxicity in children.儿童伏立康唑诱发的光毒性
Pediatr Infect Dis J. 2012 Jul;31(7):769-71. doi: 10.1097/INF.0b013e3182566311.
3
Voriconazole-associated severe hyponatremia.伏立康唑相关严重低钠血症。
Med Mycol. 2012 Jan;50(1):103-5. doi: 10.3109/13693786.2011.587210. Epub 2011 Jun 15.
4
Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers.CYP2C19基因多态性对伏立康唑在健康志愿者单次及多次给药后药代动力学的影响。
J Clin Pharmacol. 2012 Feb;52(2):195-203. doi: 10.1177/0091270010395510.
5
Voriconazole-associated salt-losing nephropathy.伏立康唑相关性失盐性肾病。
Clin Exp Nephrol. 2010 Aug;14(4):377-80. doi: 10.1007/s10157-010-0305-0. Epub 2010 Jun 22.
6
Voriconazole pharmacokinetics and pharmacodynamics in children.伏立康唑在儿童中的药代动力学和药效学
Clin Infect Dis. 2010 Jan 1;50(1):27-36. doi: 10.1086/648679.
7
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.曲霉病的治疗：美国传染病学会临床实践指南
Clin Infect Dis. 2008 Feb 1;46(3):327-60. doi: 10.1086/525258.
8
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.对侵袭性真菌病患者进行伏立康唑治疗药物监测可改善疗效和安全性结果。
Clin Infect Dis. 2008 Jan 15;46(2):201-11. doi: 10.1086/524669.
9
[Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].[伏立康唑治疗引起的肺曲霉病合并抗利尿激素分泌不当综合征病例]
Nihon Kokyuki Gakkai Zasshi. 2007 Jun;45(6):489-93.
10
PCR identification system for the genus Aspergillus and three major pathogenic species: Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger.曲霉属及三种主要致病菌种的PCR鉴定系统：烟曲霉、黄曲霉和黑曲霉。
Med Mycol. 2004 Oct;42(5):433-7. doi: 10.1080/13693780310001656786.
Zotero 插件